(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | -42.29%30.99B | ---- | ---- | ---- | 121.04%53.69B | ---- | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | -13.69%-1.8B | ---- | ---- | ---- | -20.41%-1.59B | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | -7.22%-2.26B | ---- | ---- | ---- | -1.97%-2.11B | ---- | ---- | ---- |
Impairment and provisions: | ---- | ---- | -99.11%16.76M | ---- | ---- | ---- | 85.81%1.87B | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | -94.06%44.14M | ---- | ---- | ---- | 1,397.08%743.42M | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | -103.03%-7.46M | ---- | ---- | ---- | 709.82%246.63M | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | -300.76%-176.05M | ---- | ---- | ---- | -376.03%-43.93M | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | --228K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | -83.21%155.91M | ---- | ---- | ---- | -4.82%928.52M | ---- | ---- | ---- |
Revaluation surplus: | ---- | ---- | -207.98%-126.48M | ---- | ---- | ---- | 16.23%117.13M | ---- | ---- | ---- |
-Fair value of investment properties (increase) | ---- | ---- | 60.72%-18.45M | ---- | ---- | ---- | -88.20%-46.98M | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | -165.82%-108.02M | ---- | ---- | ---- | 30.52%164.11M | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | 203.50%23.63M | ---- | ---- | ---- | 68.25%-22.83M | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | 194.86%21.66M | ---- | ---- | ---- | 60.36%-22.83M | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | --1.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | ---- | 35.81%15.47B | ---- | ---- | ---- | 2.39%11.39B | ---- | ---- | ---- |
-Depreciation | ---- | ---- | 38.99%11.39B | ---- | ---- | ---- | 4.27%8.19B | ---- | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | 19.35%3.44B | ---- | ---- | ---- | -1.74%2.88B | ---- | ---- | ---- |
Financial expense | ---- | ---- | -40.45%3.56B | ---- | ---- | ---- | 12.48%5.98B | ---- | ---- | ---- |
Unrealized exchange loss (gain) | ---- | ---- | 294.36%1.76B | ---- | ---- | ---- | -300.60%-903.59M | ---- | ---- | ---- |
Special items | ---- | ---- | 11.07%840.77M | ---- | ---- | ---- | 15.93%756.97M | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | -29.95%48.47B | ---- | ---- | ---- | 78.26%69.19B | ---- | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | 263.09%1.03B | ---- | ---- | ---- | 5.43%-633.55M | ---- | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | -21.17%2.32B | ---- | ---- | ---- | 145.60%2.94B | ---- | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | -653.02%-12.15B | ---- | ---- | ---- | -34.67%2.2B | ---- | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | -420.84%-6.34B | ---- | ---- | ---- | -44.00%-1.22B | ---- | ---- | ---- |
Special items for working capital changes | ---- | ---- | 367.19%6.5B | ---- | ---- | ---- | -63.48%1.39B | ---- | ---- | ---- |
Cash from business operations | ---- | ---- | -46.08%39.83B | ---- | ---- | ---- | 94.27%73.87B | ---- | ---- | ---- |
Other taxs | ---- | ---- | -131.05%-16.12B | ---- | ---- | ---- | -107.89%-6.98B | ---- | ---- | ---- |
Interest received - operating | ---- | ---- | 13.18%1.8B | ---- | ---- | ---- | 14.01%1.59B | ---- | ---- | ---- |
Interest paid - operating | ---- | ---- | 56.15%-2.9B | ---- | ---- | ---- | -5.79%-6.61B | ---- | ---- | ---- |
Special items of business | 89.21%9.64B | ---- | ---- | ---- | -79.71%5.1B | ---- | ---- | ---- | 376.67%25.11B | ---- |
Adjustment items of business operations | ---- | 0.45%5.47B | ---- | -50.05%19.01B | ---- | 308.44%5.44B | ---- | 96.88%38.05B | ---- | -57.80%1.33B |
Net cash from operations | 89.21%9.64B | 0.45%5.47B | -63.45%22.62B | -50.05%19.01B | -79.71%5.1B | 308.44%5.44B | 107.52%61.87B | 96.88%38.05B | 376.67%25.11B | -57.80%1.33B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | 142.80%528.93M | -11.55%31.08M | 583.56%1.02B | 155.03%570.45M | 27.00%217.85M | -41.14%35.14M | -73.91%148.52M | -58.35%223.68M | 543.73%171.53M | 26.45%59.7M |
Loan receivable (increase) decrease | 401.65%1.54B | ---- | 201.03%7.54B | ---- | -87.03%306.4M | ---- | 154.25%2.5B | ---- | 146.20%2.36B | ---- |
Decrease in deposits (increase) | -297.59%-203.49M | ---- | 17.21%-1.18B | ---- | --102.98M | ---- | -111.06%-1.43B | ---- | ---- | ---- |
Sale of fixed assets | -89.07%24.58M | -98.79%568K | 1,058.63%5.56B | -0.21%197.2M | 209.10%224.84M | 1,173,450.00%46.94M | -49.03%480.14M | 191.86%197.62M | -23.74%72.74M | -99.52%4K |
Purchase of fixed assets | 2.71%-4.58B | -26.59%-5.46B | -90.97%-6.23B | -68.94%-12.85B | -36.59%-4.71B | -285.16%-4.31B | 27.49%-3.26B | 9.24%-7.6B | -20.67%-3.45B | 50.87%-1.12B |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | -79.98%37.29M | ---- | ---- | ---- |
Purchase of intangible assets | 101.03%2.54M | ---- | -1,027.99%-2.03B | ---- | -179.94%-246.76M | ---- | 97.16%-180.05M | ---- | -3.21%-88.15M | ---- |
Sale of subsidiaries | ---- | ---- | --15.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | -59,624.99%-10.03B | ---- | -23,562.46%-15.3B | ---- | 6.20%-16.79M | ---- | 99.44%-64.65M | 98.96%-5.69M | 99.79%-17.9M | ---- |
Recovery of cash from investments | ---- | 56.03%1.54B | -38.87%87.95M | 119.54%3.13B | ---- | 77.82%985.72M | 243.29%143.89M | -34.95%1.43B | ---- | -3.57%554.34M |
Cash on investment | 46.64%-656.64M | ---- | -35.26%-18.81B | -156.68%-1.35B | -1,241.59%-1.23B | -4,273.25%-1.05B | -1,249.77%-13.9B | -168.10%-524M | 0.95%-91.72M | 95.80%-24M |
Other items in the investment business | 111.76%13.5M | -291.35%-37.06M | -95.26%16.87M | 153.58%1.15B | 92.00%-114.72M | -93.44%19.37M | -85.42%355.63M | -338.78%-2.14B | -185.99%-1.43B | --295.21M |
Net cash from investment operations | -144.47%-13.36B | 8.14%-3.93B | -93.23%-29.32B | -8.47%-9.14B | -121.03%-5.47B | -1,722.43%-4.28B | 32.48%-15.17B | -66.71%-8.43B | 82.14%-2.47B | 91.40%-234.61M |
Net cash before financing | -904.23%-3.72B | 31.88%1.54B | -114.35%-6.7B | -66.70%9.86B | -101.64%-370.61M | 6.38%1.17B | 535.76%46.7B | 107.56%29.63B | 363.85%22.64B | 155.37%1.1B |
Cash flow from financing activities | ||||||||||
New borrowing | 31.79%24.17B | 66.84%22.69B | 217.79%76.86B | 49.09%42.95B | 41.38%18.34B | 221.05%13.6B | -49.40%24.19B | -34.13%28.81B | -25.83%12.97B | -74.66%4.24B |
Refund | -16.29%-15.56B | 0.93%-11.69B | -31.64%-66.9B | 35.31%-29.78B | -63.55%-13.38B | -90.08%-11.8B | -46.44%-50.82B | -37.18%-46.03B | -47.30%-8.18B | 51.87%-6.21B |
Issuing shares | 7,790.56%4.51B | ---- | -43.79%453.56M | ---- | -92.91%57.21M | ---- | 528.14%806.92M | ---- | 656.50%806.92M | ---- |
Issuance of bonds | 8.05%8.99B | ---- | 36.22%6.8B | ---- | 66.74%8.32B | ---- | -73.55%4.99B | ---- | -44.49%4.99B | ---- |
Dividends paid - financing | 56.17%-1.06B | 53.45%-572.58M | -79.85%-24.47B | -58.99%-28.53B | 4.53%-2.41B | 53.98%-1.23B | -164.63%-13.6B | -92.05%-17.94B | ---2.53B | -39.13%-2.67B |
Absorb investment income | ---- | 29,882.00%3B | 9,876.59%4.65B | -98.86%67.21M | 653.67%373.16M | -88.00%10M | ---47.52M | -16.90%5.9B | -43.81%49.51M | -15.04%83.32M |
Issuance expenses and redemption of securities expenses | -450.69%-9.34B | ---- | ---4.12B | ---- | 77.84%-1.7B | ---- | ---- | ---- | 23.89%-7.66B | ---- |
Other items of the financing business | -242.68%-4.35B | -3,480.11%-9.68B | 137.58%5.13B | -404.60%-8.87B | 90.17%-1.27B | -847.85%-270.48M | -290.13%-13.65B | 131.81%2.91B | -572.92%-12.91B | 102.62%36.17M |
Net cash from financing operations | -12.59%7.04B | 1,100.56%3.74B | 96.19%-1.87B | 8.32%-24.16B | 162.59%8.05B | 106.89%311.88M | -407.44%-49.1B | -2,060.58%-26.36B | -196.76%-12.87B | -830.18%-4.52B |
Effect of rate | -90.52%72.65M | 27.12%-176.52M | -78.21%212.64M | -125.97%-281.5M | 328.11%765.99M | -195.16%-242.23M | 351.53%975.83M | 759.94%1.08B | -52.06%178.93M | 132.99%254.55M |
Net Cash | -56.81%3.32B | 257.04%5.29B | -257.58%-8.57B | -537.28%-14.3B | -21.38%7.68B | 143.21%1.48B | -110.28%-2.4B | -74.95%3.27B | 107.13%9.77B | -426.35%-3.43B |
Begining period cash | -21.63%30.27B | -50.15%30.27B | -3.55%38.62B | -1.98%41.11B | -3.55%38.62B | 51.61%60.71B | 133.95%40.04B | 145.06%41.94B | 133.95%40.04B | 133.96%40.05B |
Cash at the end | -28.50%33.66B | -42.90%35.38B | -21.63%30.27B | -42.69%26.53B | -5.85%47.07B | 68.01%61.95B | -3.55%38.62B | 54.30%46.3B | 125.13%50B | 101.77%36.87B |
Cash balance analysis | ||||||||||
Cash and bank balance | -28.50%33.66B | ---- | ---- | ---- | --47.07B | ---- | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | -28.50%33.66B | ---- | ---- | ---- | --47.07B | ---- | ---- | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data